Categories

Category: Health Tech Deals

#HealthTechDeals Episode 15| Clarify, Embedded Healthcare, Wildflower, Vivante Health, Gravie, Nice

We made it back from ViVE in one piece! Will Jess DaMassa stab me in the back Brutus-Style? Tune in to find out as we discuss deals: Clarify buys Embedded Healthcare; Wildflower raises $26 million; Vivante Health raises $16 million; Gravie raises $75 million; and Nice Healthcare raises $30 million.

Matthew Holt

Transcript

Jess DaMassa:

Well, we made it back from Vive all in one piece and we landed squarely in the Ides of March. Will I stab Matthew Holt in the back Brutus-style? Tune to the March 15th episode of Health Tech DEALS. Oh Matthew Holt, those ruthless Romans, never trust an Italian. That’s the lesson here.

Matthew Holt:

Well, sad enough, I trusted you and you told me to buy some stocks. And now, have you seen digital digital health talks yesterday?

Matthew Holt:

Everybody off another 10%?

Jess DaMassa:

Okay, but how does that compare with the reality of everything else right now?

Matthew Holt:

I don’t know. Somehow, Teladoc was about 300 a year ago

Jess DaMassa:

Don’t even talk to me about Teladoc.

Matthew Holt:

Now it’s around 50.

Continue reading…

#HealthTechDeals Episode 14: Elemy, Health Gorilla, M_disrupt; Flume; and Homeward Health

In this episode of Health Tech Deals, Jess and I say hello to you from Miami! Together at ViVE 2022, we weigh in on some big funding deals! We also have a short cameo along the way (watch to see who it is)! Elemy raises $215 million; Health Gorilla raises $50 million; M_disrupt raises $6 million; Flume raises $30 million; and Homeward Health raises $20 million.

TRANSCRIPT

Jessica DaMassa:

Hello from Miami. I am at ViVE and look, the exhibit hall coming down around me. Here’s what the reg area looked like. People are leaving, everybody’s got their bags and ah, look who I’ve got. Weighing in with the big funding deals from ViVE, Matthew Holt. It is the March 10th episode of Health Tech Deals. Well, we’re selfie-style here, because we are on the move.

Matthew Holt:

Yeah. You had a fantastic professional cameraman and we decided not to use him

Jessica DaMassa:

No. Instead we’re using this, but I’ve interviews for you guys coming out of this.

Matthew Holt:

Even I did some, actually a lot of stuff going on in the show, pretty interesting. And there were a few deals announced.

Continue reading…

#HealthTechDeals Episode 13: ModMed, Nayya, Sanofi, Dario Health, Ro, Dadi, and Daybreak Health

Here’s the big question of the day: VIVE or HIMSS or both? Jess and I offer our thoughts on both conferences and which ones we’re going to. Some deals in the past few days: ModMed buys Klara for $200 million; Nayaa raises $55 million; Sanofi and Dario Health have a $30 million deal; Ro acquires Dadi, an in-home sperm testing company; Daybreak Health raises $10 millionMatthew Holt

TRANSCRIPT

Jessica DaMassa:

All right, Matthew Holt, the big question of the day: ViVE or HIMSS or both? Ugh.

Matthew Holt:

Or neither?

Jessica DaMassa:

Hey, that’s the way to do it. It’s the March 3rd episode of Health Tech Deals.

Matthew Holt:

So, Jessica, I thought the big question was State of the Union versus invading Ukraine versus .. No, no, it’s all about ViVE versus HIMSS?

Jessica DaMassa:

ViVE versus HIMSS.

Continue reading…

#HealthTechDeals Episode 12: Omada Health, Somatus, Qventus, Story Health, and Medibuddy

In this episode of Health Tech Deals, Jess is back! Where was she? Out in the wilds in Arizona, hiking in mountains. A big shoutout to Ian Morrison for filling in. Some recent deals: Omada Health raises $129 million; Somatus raises $325 million; Qventus raises $50 million; Story Health raises $22.6 million; and Medibuddy raises $125 million.

TRANSCRIPT

Matthew Holt:

Hang on. You’re not Ian Morrison.

Jessica DaMassa:

I’m not.

Jessica DaMassa:

He let me come back.

Matthew Holt:

Hang on, look. And we’re together.

Jessica DaMassa:

We’re together. I went from being completely away and replaced, to being right next to you.

Continue reading…

#HealthTechDeals Episode 11: MindMaze, Memora Health, Ro, PriorAuthNow, and Equip

On this episode of Health Tech Deals, Ian Morrison is pinch-hitting for Jessica DaMassa! Ian and I worked together 25+ years ago, and he’s been sitting in Silicon Valley looking at the American health care system for a long long time. Some deals – MindMaze raises $105M; Memora Health raises $40M; Ro raises $150M; PriorAuthNow raises $25M; Equip raises $58M. Ian also shares his opinions on the American health system and the digital health space–Matthew Holt

TRANSCRIPT

Ian Morrison:

Hi there, I’m Jess DaMassa. Actually, no, Jess DaMassa. Jess DaMassa is a friend of mine and I am no Jess DaMassa. I am Ian Morrison. I am pinch hitting for Jess DaMassa, how could I possibly pinch hit? Matthew told me I had to go and put my kilt on and spruce myself up a bit. But anyway, it’s an honor, a deep honor to be here for the February 18th episode of Health Teach Deals.

Matthew Holt:

So Ian, it’s a Dan Quayle line. No, it’s not the Dan Quayle, it’s the Lloyd Bentsen line about Dan Quayle.

Ian Morrison:

Exactly.

Continue reading…

#HealthTechDeal Episode 10: ANDHealth, Ada Health, Minded, Expressable, and Curve Health

Valentine’s day…is awful. Check out this episode of HealthTechDeals to get Jessica’s and my more in-depth thoughts on the holiday. But let’s see which companies got some financial love this episode: ANDHealth gets $57 million; Ada Health gets another $30m; Minded gets $25 million; Expressable gets $15 million; Curve Health gets $12 million.

-By Matthew Holt

TRANSCRIPT

Jessica DaMassa:

Matthew Holt, was your Valentine’s Day filled with love and kisses and candies and flowers. Uh oh, I take it by the look on your face that’s a big fat no. It’s the February 15th episode of Health Tech Deals. So maybe these startups will feel a little bit more love than you feel right now. What happened?

Matthew Holt:

It’s just that Valentine’s Day in America is stupid, because your kids, I don’t remember this when you were young, because it was a long time ago, but your kids have to take Valentines to everyone in their class. It’s stupid.

Continue reading…

Quickbites: Equip; SameSky, Jenny Schneider (GC) & Calibrate

I’ve decided to try a new format for some interviews with digital health leaders. The other week I was at the Digital Health Innovation Summit in San Diego. I did a fair amount of tweeting from the conference but thought I’d also grab a few of the participants for some rapid fire interviews. They’re only 5 mins each but hopefully this “Quickbite” format will catch you up on some interesting players (even as they got buffeted a bit by the wind and the marine air corp!)–Matthew Holt

The Interviewees are. Kristina Saffran, CEO Equip; Abner Mason, CEO SameSky Health; Jennifer Schneider, ex-Livongo and now EIR at General Catalyst; & Isabelle Kenyon, CEO Calibrate: Their videos are below in order

Kristina Saffran, Equip
Abner Mason, SameSky Health
Jennifer Schneider, ex-Livongo, General Catalyst
Isabelle Kenyon, Calibrate

#HealthTechDeals Episode 9: Signify buys Caravan; Koneksa; Jasper; Vynca; Doximity

Jess & I are worried about Peleton’s CEO! Well that not worried. Signify Health buys Caravan Health for $250m ; Koneksa gets $45m; Jasper Health gets $25m; $30m for Vynca; & Doximity pays $82.5m for scheduling co Amion, while going gangbusters on its numbers. Matthew Holt

TRANSCRIPT

Jessica DaMassa:

Matthew Holt, you and our loyal listeners might recall how a few weeks ago I bring up the fact that no one is talking about Peloton and the fact that it’s killing TV characters left and right. Then what happens all of a sudden? Boom! Take out of Peloton. The stock has tanked. The CEO is gone. Thousands of people laid off. Am I the harboror of terrible things that are yet to come? It’s this episode, the February 10th episode of Health Tech Deals.

Continue reading…

#HealthTechDeals Episode 08: M&A special! ThirtyMadison & Nurx, Concerto Care, Kindbody, Calm, Withings all at it!

Will Jessica stop laughing? Will we get the intro right? Who knows! 2022 is a big M&A year and this episode is no exception: ThirtyMadison and Nurx have merged, combined they have $300 million in revenue; Concerto Care acquires Crown Health; Kindbody buys Vios Fertility Institute; Calm merges with Ripple Health; Withings buys 8Fit.

-By Matthew Holt

TRANSCRIPT

Jessica DaMassa:

I can’t.

Matthew Holt:

I’ll start.

Jessica DaMassa:

No, you can’t start.

Matthew Holt:

Welcome to Health Tech Deals. The show where Jessica DaMassa normally does this part, but she’s can’t because she’s laughing too much. It must be February the 9th, 2022 edition. Possibly? Yes? Maybe? I don’t know. Maybe Jessica will stop laughing after the break.

Continue reading…

#HealthTechDeals Episode 7: League, Reimagine Care, Resilience, Mantra Health, Physician Partners

It’s Groundhog Day and I have emerged from my little hole in the ground to let you know my predictions for funding this year for Health Tech companies! League raises $95 million; Reimagine Care raises $25 million; Resilience raises 40 euros; Mantra Health raises $22 million, and Physician Partners raises $500 million. Oh and Akili is going to SPAC, maybe -Matthew Holt

Transcript:

Jessica DaMassa:

Well, it’s Groundhog Day, and that can only mean one thing. Matthew Holt has emerged from his little hole in the ground to let us know what his prediction is for more funding in this next year for health tech companies. Will he see his shadow and be scared back into the hall? It looks like it. It’s the February 2nd episode of Health Tech Deals.

Matthew Holt:

All right. Jessica, Jessica, Jess. I know I’ve seen the movie, but I don’t understand it. If the groundhog sees his shadow because the sun is up, there’s more winter?

Jessica DaMassa:

Yes.

Continue reading…

Registration

Forgotten Password?